END STAGE CANCER

Clinical trials for END STAGE CANCER explained in plain language.

Never miss a new study

Get alerted when new END STAGE CANCER trials appear

Sign up with your email to follow new studies for END STAGE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for Late-Stage breast cancer: experimental combo targets tumors when other options fail

Disease control Recruiting now

This study tests whether a new treatment called Bria-IMT, given with an immunotherapy drug, helps people with advanced metastatic breast cancer live longer compared to standard chemotherapy. It is for patients whose cancer has not responded to available treatments. About 404 adul…

Matched conditions: END STAGE CANCER

Phase: PHASE3 • Sponsor: BriaCell Therapeutics Corporation • Aim: Disease control

Last updated May 06, 2026 16:01 UTC

END STAGE CANCER

Get alerted when new END STAGE CANCER trials appear

New hope for Late-Stage breast cancer: experimental combo targets tumors when other options fail